Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2010 Aug 9:6:457-64.
doi: 10.2147/vhrm.s5839.

Role of clevidipine butyrate in the treatment of acute hypertension in the critical care setting: a review

Ahmed S Awad  1 , Michael E Goldberg
Affiliations
Review

Role of clevidipine butyrate in the treatment of acute hypertension in the critical care setting: a review

Ahmed S Awad et al. Vasc Health Risk Manag. .

Abstract

Acutely elevated blood pressure in the critical care setting is associated with a higher risk of acute end-organ damage (eg, myocardial ischemia, stroke, and renal failure) and perioperative bleeding. Urgent treatment and careful blood pressure control are crucial to prevent significant morbidity. Clevidipine butyrate (Cleviprex) is an ultrashort-acting, third-generation intravenous calcium channel blocker. It is an arterial-selective vasodilator with no venodilatory or myocardial depressive effects. Clevidipine has an extremely short half-life of approximately 1 minute as it is rapidly metabolized by blood and tissue esterases. These metabolites are then primarily eliminated through urine and fecal pathways. The rapid onset and the short duration of action permit tighter and closer adjustment of the blood pressure than is possible with other intravenous agents.

Keywords: antihypertensive medications; calcium channel blocker; end-organ damage; hypertensive crisis; hypertensive urgency.

PubMed Disclaimer

References

    1. Varon J. Treatment of acute severe hypertension current and newer agents. Drugs. 2008;68(3):283–297. - PubMed
    1. Pollack C, Varon J, Garrison N, Ebrahimi R, Dunbar L. Clevidipine, an intravenous dihydropyridine calcium channel blocker, is safe and effective for the treatment of patients with acute severe hypertension. Ann Emerg Med. 2009;53(3):329–338. - PubMed
    1. Deeks E, Keating G, Keam S. Clevidipine: a review of its use in the management of acute hypertension. Am J Cardiovasc Drugs. 2009;9(2):117–134. - PubMed
    1. Potter JF. Malignant hypertension in the elderly. Q J Med. 1995;88:641–647. - PubMed
    1. National Heart, Lung, and Blood Institute . Seventh report of the Joint National Committee on prevention, detection, evaluation, and treatment of high blood pressure (JNC-7) 2003. Publication No. NIH 03-5233. Bethesda (MD): NIH; 2003. - PubMed